
Improving the quality of life for patients with functional mitral regurgitation
|
Mitralign is developing an innovative catheter-based technology for percutaneous treatment of functional mitral regurgitation. The novel Mitralign system rivals surgical annuloplasty. |
![]() |
Corporate HeadquartersAddress: 3 Highwood Drive, Suite 200E, Tewksbury, Massachusetts 01876 USA F: +1-978-858-0160 |
ManagementCEO: Rick Geoffrion COO/CFO: Richard J. Omilanowicz |
Giza's Team Member |
|
Fields of invesment: |
Contact info: Email Website |